Your session is about to expire
← Back to Search
Stem Cell Transplant
Cord Blood Transplant for Blood Disorders
Phase 2
Recruiting
Led By Richard W Childs, M.D.
Research Sponsored by National Heart, Lung, and Blood Institute (NHLBI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year post transplant
Awards & highlights
Study Summary
This trial will test the safety of unlicensed cord blood units in people who need stem cell transplants.
Who is the study for?
This trial is for individuals of any age and gender who need a stem cell transplant due to conditions like leukemia, lymphoma, or anemia. They must be part of another clinical trial for the transplant and give informed consent. Those already receiving unlicensed cord blood from other banks or licensed products only cannot participate.Check my eligibility
What is being tested?
The study tests the safety and effectiveness of unlicensed cord blood units used in stem cell transplants. Participants will receive these units during their standard transplant procedure and will be monitored for up to one year for any issues.See study design
What are the potential side effects?
Potential side effects are related to stem cell transplantation procedures which may include infection risk, graft-versus-host disease (where transplanted cells attack your body), bleeding complications, organ damage, and reactions to the infusion.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year post transplant
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year post transplant
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cone-Rod Dystrophy 2
Trial Design
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
at least one
Find a Location
Who is running the clinical trial?
National Heart, Lung, and Blood Institute (NHLBI)Lead Sponsor
3,836 Previous Clinical Trials
47,310,612 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,660 Previous Clinical Trials
40,924,182 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,269 Previous Clinical Trials
5,480,969 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am eligible for a stem cell transplant trial using cord blood.I am currently using approved cannabinoid-based products.You are currently receiving unapproved cord blood products from sources other than the study.
Research Study Groups:
This trial has the following groups:- Group 1: 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many people are allowed to be enrolled in this research project at one time?
"The answer is affirmative. According to the clinicaltrials.gov website, this trial is still recruiting patients. The listing for the study was first created on October 16th, 2015 and edited most recently on November 15th, 2020. They are looking for 500 people total at 2 locations."
Answered by AI
Are we still recruiting participants for this research project?
"The clinical trial is actively recruiting patients, as noted on clinicaltrials.gov. It was originally posted on October 16th, 2015 and was edited most recently on November 15th, 2022. They are looking for 500 patients from 2 different sites."
Answered by AI
Has the FDA sanctioned cord blood as a treatment?
"Although cord blood units have not been proven effective in any trials, there is some evidence to support its safety, leading our team to rate it a 2."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger